GET THE APP

A statistical consideration on the evaluation of biomarkers
..

Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

A statistical consideration on the evaluation of biomarkers


6th International Conference on Biomarkers & Clinical Research

August 31-September 02, 2015 Toronto, Canada

Laura Gillis

BioStat Solutions, Inc., USA

Posters-Accepted Abstracts: J Mol Biomark Diagn

Abstract :

As the use of multiple types of biomarkers in companion diagnostics continues to grow, evaluation and validation becomes more critical and often more complicated. While DNA biomarkers are stable over time, proteomic biomarkers can change over time depending on disease progression. Epidemiological variables, such as age, often provide additional predictive capability. Combining these biomarkers can lead to better diagnostics, but statistical analysis becomes more complex. This presentation will present techniques that have proven successful in the evaluation of diverse biomarkers for disease and drug response.

Biography :

Email: lbg@biostatsolutions.com

Google Scholar citation report
Citations: 2054

Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward